Details of the Drug

General Information of Drug (ID: DMF9B50)

• Drug Name: DRP-104
• Synonyms: Sirpiglenastat

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1/2	[1]

• Drug Type: Small molecular drug
• Cross-matching ID:
  PubChem CID: 137308771
  TTD ID: DC3ZD5

References

• [1] ClinicalTrials.gov (NCT04471415) First-in-human Study of DRP-104 (Sirpiglenastat) as Single Agent and in Combination With Atezolizumab in Patients With Advanced Solid Tumors.. U.S. National Institutes of Health.